Sprycel (Dasatinib)


New product

60x 20mg tablets 

Dasatinib is approved as a cancer medication, but recent attention has been focused on its ability to act as a senolytic; that is an agent that can remove ‘dead’ (senscent) cells within the body by inducing a process known as autophagy. 

There is no doubt that dasatinib represents the cutting-edge in anti-aging medicine, perhaps even experimental in some respects, but hardcore enthusiasts are aware that senolytics are presently a major focus of research.

The current program is considered to be as follows: 

A dose of 5 mg per Kg body weight (2.2 lbs). This dose should be divided into two and taken at least a week apart and does not need to be cycled again for 8 to 12 months.

Example: if you weigh 72 Kg (158 lbs) then the total dose is 72x 5 = 360 mg

Divide into two 360/ 2 = 180 mg so that’s the dose for week one and again in week two.

Remember that once completed, this dose does not need to be cycled again for 8 to 12 months.

All EU countries require a prescription to purchase. 




Warning: Last items in stock!

- +

Add to compare

Recently Viewed


Compare 0